RPPH1 and acute myeloid leukemia: Consistently, transfection of miR-330-5p inhibitor also partially reversed the decreased invasion ability (Figure 4E(Fig. 4)) and migration ability (Figure 4F(Fig. 4)) of AML cells with reduced expression of RPPH1.